EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

Efficacy of Different Concentrations of Autologous Serum Eye Drops in the Treatment of Ocular Surface Diseases: A Systematic Review and Meta-Analysis

Annisa Nindiana Pertiwi, Made Susiyanti

Journal of Current Ophthalmology · 2025-04 · 37 (2) · 159-171

DOI: 10.4103/joco.joco_2_25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Current Ophthalmology, online erschienen am 19.12.2025. Verfasst von Annisa Nindiana Pertiwi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the efficacy of different autologous serum eye drop (ASED) concentrations in treating ocular surface diseases.

Methods

All articles assessing the efficacy of 20%, 50%, or 100% ASED were retrieved from PubMed, Cochrane, ScienceDirect, and EBSCO electronic databases and checked for applicability. Efficacy was evaluated based on symptom scoring, corneal staining, and tear film stability, which includes tear break-up time (TBUT) and the Schirmer’s test.

Results

Seven randomized clinical trials, three cohort studies, and one prospective study were included in this review. ASED significantly improved subjective ocular symptoms (overall standardized mean differences [SMD]: −2.99; 95% confidence interval [CI]: −4.38 to −1.60), without significant difference between 20%, 50%, and 100% concentrations ( P = 0.617). Overall, TBUT also showed a considerable increase (mean differences [MD]: 1.68 s; 95% CI: 0.43–2.94), remarkably with 20% ASED (MD: 2.80; 95% CI: 1.61–4.00). In contrast, the Schirmer’s test showed no significant trend toward improvement (MD: 0.53; 95% CI: −0.78–1.84). A remarkable effect was observed in keratoepitheliopathy (overall SMD: −1.08; 95% CI: −1.85 to −0.32), especially in the 50% ASED subgroup (SMD: −1.54; 95% CI: −2.73 to −0.35). All outcomes showed high heterogeneity ( I 2 = 79.6%–97.3%). Sensitivity analyses limited to randomized controlled trials showed consistent findings, supporting the robustness of the results.

Conclusion

ASED was effective in improving subjective ocular symptoms, tear break-up time, and keratoepitheliopathy across different concentrations but did not significantly affect Schirmer’s test.

Schlagwörter

Stichwörter der Autor:innen

Autologous serumDifferent concentrationsOcular surface diseases

Autor:innen und Institutionen

  • Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia.

Zitieren

APA

Pertiwi, A. N., & Susiyanti, M. (2025). Efficacy of Different Concentrations of Autologous Serum Eye Drops in the Treatment of Ocular Surface Diseases: A Systematic Review and Meta-Analysis. Journal of Current Ophthalmology, 37(2), 159-171. https://doi.org/10.4103/joco.joco_2_25

Vancouver

Pertiwi AN, Susiyanti M. Efficacy of Different Concentrations of Autologous Serum Eye Drops in the Treatment of Ocular Surface Diseases: A Systematic Review and Meta-Analysis. Journal of Current Ophthalmology. 2025;37(2):159-171. doi:10.4103/joco.joco_2_25

BibTeX
@article{Pertiwi2025,
  author = {Pertiwi, Annisa Nindiana and Susiyanti, Made},
  title = {Efficacy of Different Concentrations of Autologous Serum Eye Drops in the Treatment of Ocular Surface Diseases: A Systematic Review and Meta-Analysis},
  journal = {Journal of Current Ophthalmology},
  year = {2025},
  volume = {37},
  number = {2},
  pages = {159--171},
  doi = {10.4103/joco.joco_2_25}
}
Kostenlos starten →